đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to assess the efficacy, safety and patient acc...
Status
Completed
Location
Westmead Hospital
Start Date
2004-06
Trial ID
NCT00216398
Treatments Being Tested
The hepatocellular carcinoma (HCC) represents more than 5% of all human mal...
Status
Completed
Location
D. Cotugno Hospital
Start Date
2007-04
Trial ID
NCT00495846
Treatments Being Tested
The objectives of the protocol is to determine the maximum tolerated dose a...
Status
Completed
Location
Antwerp University Hospital
Start Date
2015-03
Trial ID
NCT02396953
Treatments Being Tested
This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Status
Completed
Location
University of Michigan
Start Date
2010-07-19
Trial ID
NCT01137682
Treatments Being Tested
The objective of this study is to assess the efficacy of Pasireotide Long A...
Status
Unknown
Location
Erasmus Medical Center
Start Date
2015-08
Trial ID
NCT02668172
Treatments Being Tested
The morbidity and the mortality in acromegalic patients closely correspond ...
Status
Completed
Location
Department of Endocrinology, Odense University Hospital
Start Date
2002-09
Trial ID
NCT00145405
Treatments Being Tested
A multicentre, prospective, open label study of acromegalic patients evalua...
Status
Completed
Location
Klinikum Innenstadt
Start Date
2005-01
Trial ID
NCT00444873
This is an open-label, single treatment arm, multicenter study to assess th...
Status
Terminated
Location
Rigshospitalet, Endokrinologisk afdeling
Start Date
2022-05-18
Trial ID
NCT05364944
Treatments Being Tested
This is a randomized Phase II/late phase I de-escalation clinical trial wit...
Status
Recruiting
Location
Centre François BACLESSE
Start Date
2025-06-12
Trial ID
NCT06878664
Treatments Being Tested
The aim of this study is to compare the efficacy and safety of lanreotide A...
Status
Terminated
Location
Larry Kvols, MD
Start Date
2004-07
Trial ID
NCT00092287